Online Marketing Tools

Biotech stocks face volatility but boast long-term potential. In 2020, it was the year for growth-oriented health care names as the world came to grips with coronavirus and hungered for potential treatments. But in 2021, as the pandemic matured and as some of the COVID-related successes were priced in, we saw many areas take a step back – including the once-popular sector of biotechnology.